Dr. Giovanni Mauri Advocates Minimally Invasive Treatments at STARmed Event in South Korea

In a recent presentation at a STARmed-sponsored event in South Korea, Dr. Giovanni Mauri, a leading figure in interventional radiology, highlighted the new clinical practice guidelines for using minimally invasive treatments in managing malignant thyroid lesions. The guidelines, developed jointly by the European Thyroid Association and the Cardiovascular and Interventional Radiological Society of Europe, propose a shift towards less invasive management strategies for papillary thyroid microcarcinomas and differentiated thyroid carcinoma metastases.

Advancing Minimally Invasive Techniques

Dr. Mauri’s research, pivotal in advancing thyroid ablation techniques, underscores the importance of thermal ablation methods such as laser, radiofrequency, and microwave ablation as effective alternatives to traditional surgical approaches. These techniques offer the advantage of being less invasive, reducing the risks and recovery time associated with surgery.

A Multidisciplinary Approach

The guidelines recommend a multidisciplinary approach to treatment, emphasizing the role of interventional radiologists in assessing patient suitability for minimally invasive treatments based on a range of factors, including demographic, clinical, histological, and imaging characteristics. This tailored approach aims to optimize patient outcomes by minimizing more aggressive treatments’ physical and psychological impacts.

Global Impact and Future Directions

The event, which attracted specialists from around the globe, served as a platform for discussing the expanding role of minimally invasive procedures in thyroid cancer management. It highlighted the growing consensus among healthcare professionals regarding incorporating advanced ablation technologies into clinical practice. This initiative is part of a broader movement within the medical community to adopt procedures that enhance patient quality of life and offer alternatives to those facing higher risks from conventional surgery.

Dr. Mauri’s advocacy for these methods at the STARmed event reinforces the ongoing shift towards personalized, patient-centered care in oncology. The discussions and outcomes of this event are expected to influence future practices and guidelines, promoting wider acceptance and use of minimally invasive techniques in treating thyroid and other cancers.

Read more:
https://pubmed.ncbi.nlm.nih.gov/34178704

This news powered by RFAMD media services